Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $245.48 million. The enterprise value is $111.33 million.

Market Cap	245.48M
Enterprise Value	111.33M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 96.27 million shares outstanding. The number of shares has increased by 36.24% in one year.

Current Share Class	96.27M
Shares Outstanding	96.27M
Shares Change (YoY)	+36.24%
Shares Change (QoQ)	+65.27%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	54.87%
Float	71.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.76
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.18.

Current Ratio	3.60
Quick Ratio	3.50
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-74.38

Financial Efficiency

Return on equity (ROE) is -101.06% and return on invested capital (ROIC) is -57.59%.

Return on Equity (ROE)	-101.06%
Return on Assets (ROA)	-51.82%
Return on Invested Capital (ROIC)	-57.59%
Return on Capital Employed (ROCE)	-113.46%
Revenue Per Employee	n/a
Profits Per Employee	-$966,604
Employee Count	164
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.35% in the last 52 weeks. The beta is 3.17, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	3.17
52-Week Price Change	-27.35%
50-Day Moving Average	2.52
200-Day Moving Average	1.87
Relative Strength Index (RSI)	53.31
Average Volume (20 Days)	2,864,243

Short Selling Information

The latest short interest is 16.20 million, so 16.82% of the outstanding shares have been sold short.

Short Interest	16.20M
Short Previous Month	12.95M
Short % of Shares Out	16.82%
Short % of Float	22.73%
Short Ratio (days to cover)	3.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-163.42M
Pretax Income	-158.52M
Net Income	-158.52M
EBITDA	-161.65M
EBIT	-163.42M
Earnings Per Share (EPS)	-$2.41

Full Income Statement

Balance Sheet

The company has $159.93 million in cash and $25.78 million in debt, giving a net cash position of $134.15 million or $1.39 per share.

Cash & Cash Equivalents	159.93M
Total Debt	25.78M
Net Cash	134.15M
Net Cash Per Share	$1.39
Equity (Book Value)	139.47M
Book Value Per Share	1.45
Working Capital	118.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$118.86 million and capital expenditures -$1.40 million, giving a free cash flow of -$120.26 million.

Operating Cash Flow	-118.86M
Capital Expenditures	-1.40M
Free Cash Flow	-120.26M
FCF Per Share	-$1.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.24%
Shareholder Yield	-36.24%
Earnings Yield	-64.58%
FCF Yield	-48.99%

Analyst Forecast

The average price target for Cabaletta Bio is $13.50, which is 429.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	429.41%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1